Phase 2 Subcutaneous Fat Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Subcutaneous Fat
Caliway Biopharmaceuticals Co., Ltd.250 enrolled1 locationNCT07608770
Not Yet Recruiting
Phase 2
A Phase 2 Study to Evaluate the Efficacy, Safety and Tolerability of CBL 514 Injection on Thigh Subcutaneous Fat
Healthy to overweight subjects with undesirable subcutaneous fat thickness in thighs
Caliway Biopharmaceuticals Australia Pty Ltd18 enrolled1 locationACTRN12620001153909
Recruiting
Phase 2
A Phase 2a Study to Evaluate the Preliminary Efficacy and Safety of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
Healthy subjects with undesirable subcutaneous fat thickness in belly
Caliway Biopharmaceuticals Australia Pty Ltd66 enrolled1 locationACTRN12619001580167
Not Yet Recruiting
Phase 2
A Phase 1-2 Study for the Reduction of Submental Fat (Double Chin)
Unwanted subcutaneous fat in the submental area
Kythera Biopharmaceuticals Inc72 enrolledACTRN12607000243415